CXCR3 and glioma: Moreover, CXCR3 antagonist NBI‐74330 inhibited the growth of GL261 gliomas and increased the median survival time of CXCR3–/– mice, whereas NBI‐74330 did not affect the infiltration of CXCR3+ NK and NKT cells within gliomas, suggesting that CXCR3 may not be a major pathway for NK and NKT cells to enter gliomas.332